ANPEP and acute lymphoblastic leukemia: These alterations may be manifested most frequently as classical pre-B ALL without lineage aberrancy, but also as B-ALL with the expression of cell surface markers of myeloid lineage (CD13/33), or B/myeloid mixed phenotype acute leukemia (MPAL) [232].